Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Prevention of drug-related complications in cystic fibrosis.

van der Meer R, Touw DJ, Heijerman HGM.

Curr Opin Pulm Med. 2019 Sep 9. doi: 10.1097/MCP.0000000000000625. [Epub ahead of print]

PMID:
31503211
2.

First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer.

Kim SB, Meric-Bernstam F, Kalyan A, Babich A, Liu R, Tanigawa T, Sommer A, Osada M, Reetz F, Laurent D, Wittemer-Rump S, Berlin J.

Target Oncol. 2019 Sep 9. doi: 10.1007/s11523-019-00670-4. [Epub ahead of print]

PMID:
31502117
3.

Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial.

Guo Y, Ahn MJ, Chan A, Wang CH, Kang JH, Kim SB, Bello M, Arora RS, Zhang Q, He X, Li P, Dechaphunkul A, Kumar V, Kamble K, Li W, Kandil A, Cohen EEW, Geng Y, Zografos E, Tang PZ.

Ann Oncol. 2019 Sep 10. pii: mdz388. doi: 10.1093/annonc/mdz388. [Epub ahead of print]

PMID:
31501887
4.

Design and Implementation of a Tool for Pharmacists to Register Potential Errors in Prescribed Medication.

Frid S, Zapico V, Mansilla A, Álvarez M, López G, Otero C, Luna D.

Stud Health Technol Inform. 2019 Aug 21;264:581-585. doi: 10.3233/SHTI190289.

PMID:
31437990
5.
6.

Response to clopidogrel and of the cytochrome CYP2C19 gene polymorphism.

Charfi R, Mzoughi K, Boughalleb M, Hosni H, Kouidhi S, Sfar I, Hammami N, Zaïri I, Limam M, Zedini C, Mrabet A, Klouz A, Gorgi Y, Kharrat M, Baccar H, Trabelsi S.

Tunis Med. 2018 Mar;96(3):209-218.

7.

Evaluation of patients' knowledge on their vitamin K antagonist treatment.

Mzoughi K, Zairi I, BenGhorbel F, Ben Kilani M, Kamoun S, Ben Moussa F, Fennira S, Kraiem S.

Tunis Med. 2018 Mar;96(3):182-186.

8.

Association of Imatinib Plasma Concentration and Single-nucleotide Polymorphisms with Adverse Drug Reactions in Patients with Gastrointestinal Stromal Tumors.

Zhang Q, Xu J, Qian Y, Chen L, Li Q, Xu K, Chen M, Sun L, He Z, Yang L, Zhang D, Wang L, Sun X, Wang Y, Xu H, Xu Z.

Mol Cancer Ther. 2018 Dec;17(12):2780-2787. doi: 10.1158/1535-7163.MCT-18-0498. Epub 2018 Oct 3.

PMID:
30282814
9.

Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance.

Yang CC, Yang H.

Artif Intell Med. 2018 Aug;90:42-52. doi: 10.1016/j.artmed.2018.07.002. Epub 2018 Aug 6.

PMID:
30093253
10.

Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.

Sanoff HK, Goldberg RM, Ivanova A, O'Reilly S, Kasbari SS, Kim RD, McDermott R, Moore DT, Zamboni W, Grogan W, Cohn AL, Bekaii-Saab TS, Leonard G, Ryan T, Olowokure OO, Fernando NH, McCaffrey J, El-Rayes BF, Horgan AM, Sherrill GB, Yacoub GH, O'Neil BH.

Cancer. 2018 Aug 1;124(15):3118-3126. doi: 10.1002/cncr.31552. Epub 2018 Jun 15.

11.

Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib.

Gordon MJ, Churnetski M, Alqahtani H, Rivera X, Kittai A, Amrock SM, James S, Hoff S, Manda S, Spurgeon SE, Choi M, Cohen JB, Persky D, Danilov AV.

Cancer. 2018 Aug 1;124(15):3192-3200. doi: 10.1002/cncr.31554. Epub 2018 May 24.

12.

Antiviral Activity of Oral JNJ-53718678 in Healthy Adult Volunteers Challenged With Respiratory Syncytial Virus: A Placebo-Controlled Study.

Stevens M, Rusch S, DeVincenzo J, Kim YI, Harrison L, Meals EA, Boyers A, Fok-Seang J, Huntjens D, Lounis N, Mari N K, Remmerie B, Roymans D, Koul A, Verloes R.

J Infect Dis. 2018 Jul 24;218(5):748-756. doi: 10.1093/infdis/jiy227.

PMID:
29684148
13.

First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.

Baden LR, Walsh SR, Seaman MS, Cohen YZ, Johnson JA, Licona JH, Filter RD, Kleinjan JA, Gothing JA, Jennings J, Peter L, Nkolola J, Abbink P, Borducchi EN, Kirilova M, Stephenson KE, Pegu P, Eller MA, Trinh HV, Rao M, Ake JA, Sarnecki M, Nijs S, Callewaert K, Schuitemaker H, Hendriks J, Pau MG, Tomaka F, Korber BT, Alter G, Dolin R, Earl PL, Moss B, Michael NL, Robb ML, Barouch DH; IPCAVD006/RV380/HIV-V-A002 Study Group.

J Infect Dis. 2018 Jul 13;218(4):633-644. doi: 10.1093/infdis/jiy212.

14.

Core Outcome Set for Trials Aimed at Improving the Appropriateness of Polypharmacy in Older People in Primary Care.

Rankin A, Cadogan CA, In Ryan C, Clyne B, Smith SM, Hughes CM.

J Am Geriatr Soc. 2018 Jul;66(6):1206-1212. doi: 10.1111/jgs.15245. Epub 2018 Feb 20.

PMID:
29461621

Supplemental Content

Loading ...
Support Center